RT - Journal TY - JOUR A1 - Hongal, Amrita A1 - Revathi, T A1 - Radhika, Seetharampura A1 - Shilpa, Kanathur T1 - Myriads of cutaneous manifestations with Nilotinib, treated by acitretin – a case report YR - 2020/7/1 JF - Indian Journal of Drugs in Dermatology JO - Indian J Drugs Dermatol SP - 85 OP - 87 VO - 6 IS - 2 UL - https://www.ijdd.in/article.asp?issn=2455-3972;year=2020;volume=6;issue=2;spage=85;epage=87;aulast=Hongal;t=5 DO - 10.4103/ijdd.ijdd_13_20 N2 - A remarkable advancement is been made in the treatment of cancer, through chemotherapeutic drugs like tyrosine kinase inhibitors (TKI), etc. Chemotherapy induced cutaneous side effects are multiple and usually they are underreported. Nilotinib is a second generation TKI, which is approved for imatinib resistant CML. Various cutaneous and its appendageal changes have been noticed with the use of nilotinib usage. Here, we report such case of a 34 year old male, who is a case of CML being treated with Nilotinib for 2.5 years, presented to us with perforating folliculitis, psoriasiform dermatosis, KP like lesions, madarosis and textural changes of scalp hair. ER -